Yoburn BC, Shah S, Chan K, Duttaroy A, Davis T. Supersensitivity to opioid analgesics following chronic opioid antagonist treatment : relationship to receptor selectivity. Pharmacol Biochem Behav 1995 ; 51 : 535-9.
Kalso E, Vainio A, Mattila MJ, Rosenberg PH, Seppälä T. Morphine and oxycodone in the management of cancer pain : plasma levels determined by chemical and radioreceptor assays. Pharmacol Toxicol 1990 ; 67 : 322-8.
Ross FB, Smith MT. The intrinsic antinociceptive effects of oxycodone appear to be kappa-opioid receptor mediated. Pain 1997 ; 73 : 151-7.
Nielsen CK, Ross FB, Lotfipour S, Saini KS, Edwards SR Smith MT. Oxycodone and morphine have distinctly different pharmacological profiles : radioligand binding and behavioural studies in two rat models of neuropathic pain. Pain 2007 ; 132 : 289-300.
Leow KP, Smith MT, Williams B, Cramond T. Single-dose and steady-state pharmacokinetics and pharmacodynamics of oxycodone in patients with cancer. Clin Pharmacol Ther 1992 ; 52 : 487-95.